Yu Ri Im
Impact in
- Health Informatics top 5%
- Artificial Intelligence in Healthcare and Education
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Hepatitis B Virus Studies 3
- Liver Disease Diagnosis and Treatment 2
-
- Renal cell carcinoma treatment 1
- Co-authors
- Dana W.Y. Tsui (1 shared paper)Luis A. Díaz (1 shared paper)Jonathan C. M. Wan (1 shared paper)James Mackay (1 shared paper)Sarah Hickman (1 shared paper)Fiona J. Gilbert (1 shared paper)Elizabeth Le (1 shared paper)Ramona Woitek (1 shared paper)
- Journals
- The Lancet. Gastroenterology & hepatology (2 papers)eLife (1 paper)Journal of Hepatology (1 paper)Hepatology (1 paper)Trends in cancer (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Yu Ri Im
7 papers receiving 345 citations
Peers
Comparison fields: 5 of 81
- Health Informatics 29
- Hepatology 49
- Epidemiology 139
- Cancer Research 38
- Endocrinology, Diabetes and Metabolism 34
Countries citing papers authored by Yu Ri Im
This map shows the geographic impact of Yu Ri Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ri Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ri Im more than expected).
Fields of papers citing papers by Yu Ri Im
This network shows the impact of papers produced by Yu Ri Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ri Im. The network helps show where Yu Ri Im may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Ri Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 123 | |
| 2 | 2021 | 84 | |
| 3 | 2020 | 45 | |
| 4 | 2022 | 43 | |
| 5 | 2021 | 37 | |
| 6 | 2020 | 9 | |
| 7 | 2022 | 6 | |
| 8 | 2026 | 0 | |
| 9 | 2022 | 0 |
About Yu Ri Im
Yu Ri Im is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Artificial Intelligence, having authored 9 papers that have together received 347 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Hepatitis C virus research (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Health Informatics (29 citations), Hepatology (49 citations), Epidemiology (139 citations), Cancer Research (38 citations) and Endocrinology, Diabetes and Metabolism (34 citations). Yu Ri Im has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Dana W.Y. Tsui, Luis A. Díaz, Jonathan C. M. Wan, James Mackay, Sarah Hickman, Fiona J. Gilbert, Elizabeth Le, Ramona Woitek, Angelica I. Avilés-Rivero and Gabrielle Baxter. Their work appears in journals such as The Lancet. Gastroenterology & hepatology, eLife, Journal of Hepatology, Hepatology and Trends in cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.